Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma.

Villanueva GI, Alarcón S, Bonilla D, Casanovas A, Chaparro M, Coirini MD, Felizzia G, Figueredo D, Fuentes-Alabi S, Ferman S, Franco S, Garcia Lombardi M, Gaytan Morales F, Gregianin LJ, González Ramella Ó, Halley N, Hashimoto C, Ikeda A, Howard S, Juárez Villegas LE, Morosini F, Olaya Vargas A, Odone-Filho V, Pereira de Carvalho Filho N, Peters C, Pérez V, Pérez García M, Pollono A, Rosado R, Romero L, Salazar Rosales HDP, Silva B, Sobrero V, Streitenberger DP, Valencia D, Varela M, Villarroel M

Open source

DOI: 10.1200/go-25-00201
Published: 2025 Dec
Container: JCO global oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/go-25-00201,
  title = {Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma.},
  author = {Villanueva GI and Alarcón S and Bonilla D and Casanovas A and Chaparro M and Coirini MD and Felizzia G and Figueredo D and Fuentes-Alabi S and Ferman S and Franco S and Garcia Lombardi M and Gaytan Morales F and Gregianin LJ and González Ramella Ó and Halley N and Hashimoto C and Ikeda A and Howard S and Juárez Villegas LE and Morosini F and Olaya Vargas A and Odone-Filho V and Pereira de Carvalho Filho N and Peters C and Pérez V and Pérez García M and Pollono A and Rosado R and Romero L and Salazar Rosales HDP and Silva B and Sobrero V and Streitenberger DP and Valencia D and Varela M and Villarroel M},
  year = {2025},
  journal = {JCO global oncology},
  doi = {10.1200/go-25-00201},
  url = {https://doi.org/10.1200/go-25-00201}
}

RIS

TY  - JOUR
TI  - Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma.
AU  - Villanueva GI
AU  - Alarcón S
AU  - Bonilla D
AU  - Casanovas A
AU  - Chaparro M
AU  - Coirini MD
AU  - Felizzia G
AU  - Figueredo D
AU  - Fuentes-Alabi S
AU  - Ferman S
AU  - Franco S
AU  - Garcia Lombardi M
AU  - Gaytan Morales F
AU  - Gregianin LJ
AU  - González Ramella Ó
AU  - Halley N
AU  - Hashimoto C
AU  - Ikeda A
AU  - Howard S
AU  - Juárez Villegas LE
AU  - Morosini F
AU  - Olaya Vargas A
AU  - Odone-Filho V
AU  - Pereira de Carvalho Filho N
AU  - Peters C
AU  - Pérez V
AU  - Pérez García M
AU  - Pollono A
AU  - Rosado R
AU  - Romero L
AU  - Salazar Rosales HDP
AU  - Silva B
AU  - Sobrero V
AU  - Streitenberger DP
AU  - Valencia D
AU  - Varela M
AU  - Villarroel M
PY  - 2025
JO  - JCO global oncology
DO  - 10.1200/go-25-00201
UR  - https://doi.org/10.1200/go-25-00201
ER  -

APA

GI, V., S, A., D, B., A, C., M, C., MD, C., G, F., D, F., S, F., S, F., S, F., M, G. L., F, G. M., LJ, G., Ó, G. R., N, H., C, H., A, I., S, H., LE, J. V., F, M., A, O. V., V, O., N, P. D. C. F., C, P., V, P., M, P. G., A, P., R, R., L, R., HDP, S. R., B, S., V, S., DP, S., D, V., M, V., & M, V. (2025). Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma.. JCO global oncology. https://doi.org/10.1200/go-25-00201

Source records

pubmed · retrieved 2026-09-26T22:36:23.002Z